Category: Process guidance
NCMAG124 Bevacizumab advice document: July 2025
NCMAG124 Bevacizumab advice document. Published July 2025
NCMAG123 Bevacizumab advice document: July 2025
NCMAG123 Bevacizumab advice document. Published July 2025
Summary of operational arrangements for Triheptanoin in NHS Scotland. EAMS number 41104/0001
Summary of operational arrangements for Triheptanoin in NHS Scotland. EAMS number 41104/0001
Child and adolescent mental health services inspection methodology: May 2025
Summary This document sets out the methodology that we will use to carry out child and adolescent mental health services […]
Adverse events toolkit: April 2025
Adverse events toolkit: April 2025
NCMAG121 Nivolumab in combination with ipilimumab advice document: April 2025
NCMAG121 Nivolumab in combination with ipilimumab advice document : April 2025
NCMAG122 Pembrolizumab advice document: April 2025
NCMAG122 Pembrolizumab advice document : April 2025
Quality Improvement Framework for dementia post-diagnostic support in Scotland: March 2025
Quality Improvement Framework for dementia post-diagnostic support in Scotland: March 2025
NCMAG119 Pomalidomide in combination with dexamethasone advice document: February 2025
NCMAG119 Pomalidomide in combination with dexamethasone advice document: February 2025
NCMAG120 Pomalidomide in combination with bortezomib plus dexamethasone advice document: February 2025
NCMAG120 Pomalidomide in combination with bortezomib plus dexamethasone advice document: February 2025